Ventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Ventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc. The approval relates to change…
-
FDA approval · 2020-05-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for amiodarone hydrochloride from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation [NA]
A completed clinical trial investigating renal sympathetic denervation as an adjunct to catheter-based ablation for ventricular tachycardia;…
-
FDA approval · 2020-03-06FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (ALTATHERA Pharmaceuticals, LLC)
FDA approves a supplemental application for sotalol hydrochloride from ALTATHERA Pharmaceuticals, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia [Phase 3]
Phase 3 trial comparing catheter ablation to amiodarone for shock prevention in patients with defibrillators and ventricular tachycardia; st…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients [NA]
Completed clinical trial investigating renal sympathetic denervation to suppress tachyarrhythmias in ICD recipients.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events [NA]
Clinical trial INTERVENE investigating endocardial ventricular substrate ablation for preventing recurrent ventricular tachycardia events ha…
-
FDA approval · 2019-11-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
The FDA approved a supplemental application for Amiodarone hydrochloride from Dr. Reddy's Laboratories, enabling the generic product's marke…
-
FDA approval · 2019-11-14FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for propafenone hydrochloride from Rising Pharma Holdings, providing a generic version of the an…
-
FDA approval · 2019-11-13FDA Approved: PROCAINAMIDE HYDROCHLORIDE — Supplemental Application (International Medication Systems, Limited)
FDA approved a supplemental application for Procainamide hydrochloride from International Medication Systems, Limited.
-
FDA approval · 2019-11-13FDA Approved: PROPAFENONE HCL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Propafenone HCl, marking the approval of a generic Propafenone hydrochloride product from Actavi…
-
FDA approval · 2019-10-29FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Amiodarone Hydrochloride from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia [NA]
A completed clinical trial assessing inducibility and stability of ventricular tachycardia inpatients undergoing VT ablation under general a…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia [Phase 1, Phase 2]
A Phase I/II study evaluating electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia has completed enrollmen…
-
FDA approval · 2019-08-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for amiodarone hydrochloride, granting approval for a generi…
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Contrast ICE for Myocardial Scar in VT Ablations [NA]
Clinical trial update for Contrast ICE in ventricular tachycardia ablations completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection. [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of nifekalant hydrochloride injection for ventricular tachycardia and ventricular …
-
CLINICAL_TRIALS research · 2019-02-11Clinical Trial Update: Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia [NA]
This clinical trial is a prospective randomized study evaluating the effect of stellate ganglion block in patients with medically refractory…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads [NA]
Clinical trial update on septal positioning of ventricular ICD leads by Abbott Medical Devices. The study involved ventricular tachycardia a…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: 50/50% Tilt and Tuned Defibrillation Waveform [NA]
A completed clinical trial sponsored by Abbott Medical Devices evaluated a 50/50% tilt and tuned defibrillation waveform for defibrillation …
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: PAtient NOtifier Feature for Reduction of Anxiety [NA]
This update reports the completion of a clinical trial evaluating a Patient Notifier Feature intended to reduce anxiety in patients with ven…
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical (SJM) Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.
Clinical trial evaluating inducible monomorphic ventricular tachycardia in patients with Abbott St. Jude Medical ICD or CRT-D systems has be…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) [NA]
ClinicalTrials.gov entry reports the completed DAVID II trial evaluating dual-chamber and VVI implantable defibrillators. The sponsor is Abb…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy [NA]
A completed clinical trial update examines substrate modification as an adjunct to implantable cardioverter-defibrillator therapy for patien…